Bank Of New York Mellon Corp Glycomimetics Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.25 - $4.05 $31,465 - $101,946	25,172 New	25,172 $31.7 Million
Q4 2022 Feb 14, 2023	BUY	$0.57 - $3.03 $14,915 - $79,289	26,168 New	26,168 $79,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.15 $32 - $70	-61 Reduced 0.23%	26,238 $16,000
Q3 2021 Nov 12, 2021	SELL	$1.8 - $2.39 $657 - $872	-365 Reduced 1.37%	26,299 $58,000
Q2 2021 Aug 11, 2021	SELL	$2.16 - $3.18 $236,893 - $348,760	-109,673 Reduced 80.44%	26,664 $61,000
Q1 2021 May 13, 2021	BUY	$2.89 - $4.22 $11,863 - $17,323	4,105 Added 3.1%	136,337 $410,000
Q4 2020 Feb 09, 2021	BUY	$2.69 - $4.24 $8,104 - $12,775	3,013 Added 2.33%	132,232 $497,000
Q3 2020 Nov 12, 2020	BUY	$3.07 - $5.0 $9,246 - $15,060	3,012 Added 2.39%	129,219 $396,000
Q2 2020 Aug 12, 2020	BUY	$2.06 - $3.76 $8,849 - $16,152	4,296 Added 3.52%	126,207 $474,000
Q1 2020 May 06, 2020	BUY	$1.83 - $5.41 $16,248 - $48,035	8,879 Added 7.86%	121,911 $277,000
Q4 2019 Feb 14, 2020	SELL	$4.03 - $6.5 $97,719 - $157,612	-24,248 Reduced 17.66%	113,032 $597,000
Q3 2019 Nov 07, 2019	SELL	$2.8 - $12.85 $24,390 - $111,936	-8,711 Reduced 5.97%	137,280 $591,000
Q2 2019 Aug 12, 2019	SELL	$10.6 - $13.12 $3,932 - $4,867	-371 Reduced 0.25%	145,991 $1.74 Million
Q1 2019 May 14, 2019	BUY	$9.96 - $13.44 $21,902 - $29,554	2,199 Added 1.53%	146,362 $1.82 Million
Q4 2018 Feb 11, 2019	BUY	$8.47 - $14.71 $23,021 - $39,981	2,718 Added 1.92%	144,163 $1.37 Million
Q3 2018 Nov 09, 2018	BUY	$13.7 - $17.12 $42,017 - $52,507	3,067 Added 2.22%	141,445 $0
Q2 2018 Aug 06, 2018	BUY	$14.63 - $19.19 $1.53 Million - $2 Million	104,248 Added 305.44%	138,378 $2.23 Million
Q1 2018 May 15, 2018	SELL	$16.06 - $25.35 $860,253 - $1.36 Million	-53,565 Reduced 61.08%	34,130 $554,000
Q4 2017 Feb 09, 2018	BUY	$10.51 - $17.22 $921,674 - $1.51 Million	87,695	87,695 $1.47 Million

Others Institutions Holding GLYC

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account